Epstein-Barr Virus Early Antigen (EBV EA) (AA 306-390) Peptide
EBV EA
适用: Epstein-Barr Virus (EBV)
宿主: 大肠杆菌（E. Coli）
ELISA, WB
Quick Overview for Epstein-Barr Virus Early Antigen (EBV EA) (AA 306-390) Peptide (ABIN2129000)
抗原
EBV EA
(Epstein-Barr Virus Early Antigen (EBV EA))
宿主
Epstein-Barr Virus (EBV)
资源
大肠杆菌（E. Coli）
应用范围
ELISA, Western Blotting (WB)
-
-
蛋白类型
- Recombinant
-
蛋白结构域
- AA 306-390
-
产品特性
-
Purified recombinant EBV EA protein
Expression System: E.coli -
纯化方法
- Proprietary chromatographic technique
-
纯度
- > 95 % pure
-
-
-
应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
-
限制
- 仅限研究用
-
-
-
缓冲液
- 50 mM tris-HCl, pH 8.0, with 10 mM glutation, 60 mM NaCl and 0.5 % sarcosyl.
-
注意事项
- Avoid repeated freeze/thaw cycles.
-
储存条件
- RT/-20 °C
-
-
- EBV EA (Epstein-Barr Virus Early Antigen (EBV EA))
-
物质类
- Viral Protein
-
背景
-
The Epstein-Barr virus (EBV), also called Human herpes virus 4 (HHV-4), is a virusof the herpes family (which includes Herpes simplex virusand Cytomegalo virus. On infecting the B-lymphocyte, the linear virus genome circularizes and the virus subsequently persists within the cell as an episome. The virus can execute several distinct programs of gene expressionwhich can be broadly categorized as being lytic cycle or latent cycle. The lytic cycleor productive infection results in staged expression of a host of viral proteinswith the ultimate objective of producing infectious virions. Formally, this phase of infection does not inevitably lead to lysis of the host cellas EBV virions are produced by budding from the infected cell. The latent cycle(lysogenic) programs are those that do not result in production of virions.
Alternative Names: EBV HHV4 EA protein, Epstein Barr, Epstein-Barr Virus Early Antigen protein
抗原
-
You are here:
